Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Davita Inc (DVA) vs Nvidia Corp (NVDA) Price & Performance

Davita IncTrade
Nvidia CorpTrade

Price performance (Past 24H)

Key statistics

Davita Inc vs Nvidia Corp — how do they compare? Davita Inc trades at $232 (market cap $15.12B), while Nvidia Corp trades at $211.05 (market cap $4.93T). The key difference: Nvidia Corp is far larger — about 326.1× Davita Inc's market cap, and Nvidia Corp pays a 0.49% dividend while Davita Inc pays none. Which is the better fit depends on your goals.

DVANVDA
Market Cap
$15.12B$4.93T
Sector
HealthTechnology
52-Week High
$235.71$235.75
52-Week Low
$103.87$165.17
Enterprise Value
$27.67B$4.86T
Dividend Yield
0.49%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Davita Inc

No Aura AI signal available yet.

Nvidia Corp

NVIDIA (NVDA) trades at $203.53, down 3.52% on the day, with a bullish technical outlook supported by moving averages and key support at $201. The company reported strong revenue growth to $130.50B in 2025, with net income surging to $72.88B and a robust net margin of 55.84%. Recent earnings beats and a consensus analyst price target of $325.86 highlight strong fundamental momentum amid AI-driven demand.

Outlook remains positive with AI infrastructure expansion driving growth, though risks include increased competition and market volatility. Wall Street sentiment is bullish with 75% buy ratings, but investors should monitor execution risks and macroeconomic headwinds that could impact valuation multiples.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Davita Inc

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Read more on DVA

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

Read more on NVDA